GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Net Margin %

DT&CRO Co (XKRX:383930) Net Margin % : -70.42% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. DT&CRO Co's Net Income for the three months ended in Mar. 2024 was ₩-4,633 Mil. DT&CRO Co's Revenue for the three months ended in Mar. 2024 was ₩6,579 Mil. Therefore, DT&CRO Co's net margin for the quarter that ended in Mar. 2024 was -70.42%.

The historical rank and industry rank for DT&CRO Co's Net Margin % or its related term are showing as below:

XKRX:383930' s Net Margin % Range Over the Past 10 Years
Min: -98.41   Med: 2.5   Max: 13.21
Current: -98.41


XKRX:383930's Net Margin % is ranked better than
54.24% of 1027 companies
in the Biotechnology industry
Industry Median: -154.15 vs XKRX:383930: -98.41

DT&CRO Co Net Margin % Historical Data

The historical data trend for DT&CRO Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Net Margin % Chart

DT&CRO Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Margin %
-6.95 13.21 11.94 -62.57

DT&CRO Co Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.22 -24.90 -41.23 -1,703.28 -70.42

Competitive Comparison of DT&CRO Co's Net Margin %

For the Biotechnology subindustry, DT&CRO Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DT&CRO Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DT&CRO Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where DT&CRO Co's Net Margin % falls into.



DT&CRO Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

DT&CRO Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-16635.631/26586.277
=-62.57 %

DT&CRO Co's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-4633.068/6579.29
=-70.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DT&CRO Co  (XKRX:383930) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


DT&CRO Co Net Margin % Related Terms

Thank you for viewing the detailed overview of DT&CRO Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


DT&CRO Co (XKRX:383930) Business Description

Traded in Other Exchanges
N/A
Address
28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042
DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines